HopeStage
Back to all studies
UnknownNCT05599126

Mianserin versus lorazepam, each with escitalopram, for depression with sleep problems

About this titleRead the official source — NCT05599126

This study evaluates the effectiveness of Mianserin for people with depression.

Medication studyAges 18–60China
The study in practice

Understand this study

What is this study about?

This study evaluates the effectiveness of Mianserin for people with depression.

Who could participate?

This study is for people with depression. Listed age limits: 18 years to 60 years. Other eligibility criteria apply.

Listed locations
ShanghaiSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateEstimated: July 1, 2024
Recruitment status
Unknown
Enrollment listed in the registry
300
Sponsor
Zhenghui YI
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
China
Age range
From 18 Years to 60 Years
Official registry ID
NCT05599126
Official title
Show the full official title

A Multicenter Open Study of the Efficacy of Mianserin in Combination With SSRIs in Patients With Depression With Sleep Problems

Recruitment & locations

Status unknown

Shanghai

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

What is this study about?

This study evaluates the effectiveness of Mianserin for people with depression.

Who is behind this study?

The study sponsor is Zhenghui YI.

Does this study involve medication?

Yes. The study involves medication, including Mianserin and Lorazepam.

Who can participate?

This study is for people with depression. Listed age limits: 18 years to 60 years. Other eligibility criteria apply.

Want to explore more studies?

Explore studies